NCT05584319View on ClinicalTrials.gov

EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2025

Conditions
Heart FailureHeart Failure With Preserved Ejection Fraction
Interventions
DRUG

Empagliflozin 10 Mg

subjects in Empagliflozin group takes Empagliflozin 10mg per day

Trial Locations (1)

110004

Shengjing Hospital, Shenyang

All Listed Sponsors
lead

Zhijun Sun

OTHER